NCT03870893

Brief Summary

This research analyzes whether hippotherapy improves the physical activity, cardiopulmonary fitness, and attention in children with cerebral palsy and whether this enhances their general health and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2017

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 26, 2017

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

March 12, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2020

Completed
5 months until next milestone

Results Posted

Study results publicly available

August 5, 2020

Completed
Last Updated

August 5, 2020

Status Verified

July 1, 2020

Enrollment Period

2.7 years

First QC Date

July 26, 2017

Results QC Date

May 31, 2020

Last Update Submit

July 21, 2020

Conditions

Keywords

cerebral palsyhippotherapycardiopulmonary fitnessphysical activityattention

Outcome Measures

Primary Outcomes (1)

  • Change of Clinical Global Improvement(CGI)

    The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Possible ratings are 1=normal, not at all ill; 2=borderline mentally ill; 3=mildly ill; 4=moderately ill; 5=markedly ill; 6=severely ill; 7=among the most extremely ill patients. Lower values represent a better outcome. The Clinical Global Impression - Improvement scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. and rated as 1= very much improved; 2=much improved; 3=minimally improved; 4=no change; 5=minimally worse; 6=much worse; 7=very much worse. Higher values represent a better outcome.

    Change in baseline CGI at 16weeks

Secondary Outcomes (18)

  • Change of Attention

    Change in baseline attention at 16weeks

  • Change of Physical Activity(%)

    Change in baseline physical activity at 16weeks

  • Change of Peak Oxygen Uptake(VO2peak)

    Change in baseline peak oxygen uptake at 16weeks

  • Change of Gross Motor Function Measure 66

    Change in baseline Gross Motor Function Measure 66 at 16weeks

  • Change of Physical Activity(Steps)

    Change in baseline steps at 16weeks

  • +13 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention is administered to patients in this Arm.

Behavioral: hippotherapy

control group

NO INTERVENTION

No intervention

Interventions

hippotherapyBEHAVIORAL

16weeks hippotherapy program

Intervention group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • diagnosis of spastic CP
  • GMFCS level I-III
  • weight \< 35kg
  • ability to walk independently with or without an assistive device
  • ability to comply with the study protocol and follow verbal directions

You may not qualify if:

  • botulinum toxin injection within 3 months
  • orthopedic surgery within 1 year (difficulty performing one step instructions)
  • moderate to severe intellectual disability
  • uncontrolled seizure
  • poor visual or hearing acuity
  • patients who weigh more than 35 kg
  • hip dislocation
  • scoliosis more than 30 degrees
  • musculoskeletal surgery within 1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center

Seoul, 06351, South Korea

Location

Related Publications (3)

  • Suk MH, Kwon JY. Effect of Equine-Assisted Activities and Therapies on Cardiorespiratory Fitness in Children with Cerebral Palsy: A Randomized Controlled Trial. J Integr Complement Med. 2022 Jan;28(1):51-59. doi: 10.1089/jicm.2021.0158.

  • Ahn B, Joung YS, Kwon JY, Lee DI, Oh S, Kim BU, Cha JY, Kim JH, Lee JY, Shin HY, Seo YS. Effects of equine-assisted activities on attention and quality of life in children with cerebral palsy in a randomized trial: examining the comorbidity with attention-deficit/hyperactivity disorder. BMC Pediatr. 2021 Mar 19;21(1):135. doi: 10.1186/s12887-021-02597-0.

  • Park IK, Lee JY, Suk MH, Yoo S, Seo YG, Oh JK, Kwon JY. Effect of Equine-Assisted Activities on Cardiac Autonomic Function in Children with Cerebral Palsy: A Pilot Randomized-Controlled Trial. J Altern Complement Med. 2021 Jan;27(1):96-102. doi: 10.1089/acm.2020.0346. Epub 2020 Nov 27.

MeSH Terms

Conditions

Cerebral PalsyMotor ActivityCognition Disorders

Interventions

Equine-Assisted Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehaviorNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Animal Assisted TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Jeong-Yi Kwon
Organization
Samsung Medical Center

Study Officials

  • Minhwa Suk

    Researcher

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 26, 2017

First Posted

March 12, 2019

Study Start

July 5, 2017

Primary Completion

February 28, 2020

Study Completion

February 28, 2020

Last Updated

August 5, 2020

Results First Posted

August 5, 2020

Record last verified: 2020-07

Locations